ERBB2 and breast cancer: Here, we retrospectively analyzed 579 metastatic breast cancer patients from our next-generation sequencing (NGS) database with comprehensive clinicopathological features, including HER2 statuses in both primary and metastatic tumors, metastasis sites and clinical outcomes.